UK Reported by people summary by AI
A personalised cancer vaccine reduced recurrence risk in a major clinical trial, per its headline
A personalised cancer vaccine lowered the risk of the disease returning in patients, according to a report aggregated by Google. The claim relates to a major clinical trial, though details of the trial's design, the cancer type involved and the scale of the reduction have not been specified. The finding has not yet been confirmed by other outlets or by the researchers themselves.
Who's reporting this
Each one independently owned. Read it at the source.
How the Paper works. We count each story's independent sources, not the same wire filed ten times, and show the confidence out loud. One bar means one outlet so far; five is as close to nailed-on as news gets. This page updates as the edition refiles.
